Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2018

May 24, 2018

35146_dirs_2018-05-24_8eef0955-29a0-4e4e-87b4-9d05d6afaf71.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2018-05-23

Reporting Person: Rafaeli Dolev (Director, CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-23 STRATA Stock Options (right to buy) $1.66 A 1413249 Acquired 2028-05-23 Common Stock (1413249) Direct

Footnotes

F1: The Options shall be exercisable in twelve equal quarterly installments commencing on August 23, 2018 and continuing through May 23, 2020.